Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a leading innovator in the medical technology industry, primarily focused on the development, manufacturing, and sales of heart valve systems and critical care monitoring solutions. Renowned for its expertise in heart valve therapy, the company provides transcatheter aortic valve replacement (TAVR) technologies and surgical valve replacement products, significantly impacting the cardiovascular sector. Edwards Lifesciences addresses the needs of patients suffering from heart disease, offering life-saving solutions that are pivotal to interventional cardiology and cardiac surgery. Headquartered in Irvine, California, the company also develops hemodynamic monitoring systems for use in surgical and intensive care settings. Their advanced monitoring products are instrumental in informing precise patient care decisions, thereby aiding healthcare professionals in managing critically ill patients. Edwards Lifesciences operates globally, with a presence in numerous markets across North America, Europe, Asia, and the Pacific, underscoring its role as a significant player in medical innovation and healthcare advancement.